Skip to main content
. 2021 Jun 23;12:640083. doi: 10.3389/fimmu.2021.640083

Table 3.

Allele and genotype frequencies in patients with SSc and controls.

Gene SNP Allele Frequency (%) Genotype Frequency (%)
Allele Case/control (%) P OR (95%CI) Genotype Case/control (%) P χ2
GTF2I rs117026326 T 166/192 (24.6/13.9) 6.97E-10 2.22 (1.72-2.86) TT 23/10 (6.8/1.4) 6.25E-09 37.78
C 510/1190 (75.4/86.1) TC 120/172 (35.5/24.9)
CC 195/509 (57.7/73.7)
rs73366469 C 181/228 (26.8/16.6) 1.33E-08 2.02 (1.58-2.57) CC 26/14 (7.7/2.0) 1.67E-08 35.82
T 495/1148 (73.2/83.4) TC 129/200 (38.2/29.1)
TT 183/474 (54.1/68.9)
NFKB1 rs1599961 A 308/560 (40.8/45.3) 0.086 1.19 (0.97-1.46) AA 63/124 (18.5/18.1) 0.014 8.51
G 372/814 (59.2/54.7) AG 182/312 (53.5/45.4)
GG 95/251 (28.0/36.5)
TYK2 rs2304256 A 296/626 (45.4/43.5) 0.592 0.95 (0.77-1.56) AA 67/140 (19.7/20.3) 0.599 1.03
C 384/754 (54.6/56.5) CA 162/346 (47.7/50.1)
CC 111/204 (32.6/29.6)

SSc, systemic sclerosis.